A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors

Clinical trial NCT00841191 · COMPLETED

Trial details

NCT number: NCT00841191
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Pancreatic Neoplasms Colorectal Neoplasms Head and Neck Neoplasms Lung Neoplasms

Start date: 2009-03-01
Primary completion: 2011-04-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.